Status:
UNKNOWN
An Observational Study of Bevacizumab in Chinese Patients With Metastatic Colorectal Cancer
Lead Sponsor:
Peking University
Conditions:
Metastatic Colorectal Cancer
Eligibility:
All Genders
Brief Summary
This observational, multicenter, prospective study will evaluate the use of bevacizumab in real clinical practice in chinese patients with metastatic colorectal cancer.
Eligibility Criteria
Inclusion
- histologically confirmed metastatic colorectal cancer patients Having initiated treatment with bevacizumab
Exclusion
- non-metastatic colorectal cancer patients not recieved bevacizumab
Key Trial Info
Start Date :
June 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2015
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT01860144
Start Date
June 1 2012
End Date
December 1 2015
Last Update
May 19 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Cancer Hospital
Beijing, Beijing Municipality, China, 100142